Tempest Therapeutics raises about $2.5M in private placement
Tempest Therapeutics completed a private placement raising approximately $2.5 million via pre-funded warrants bundled with Series C and Series D common warrants, with additional potential proceeds of about $5 million upon cash exercise of the common warrants.
5 million through pre-funded warrants tied to Series C and Series D common warrants. The company said the common warrants could generate about $5 million more if exercised for cash. Tempest said it entered into a Securities Purchase Agreement.